Disease Information
General Information of the Disease (ID: DIS00125)
Name |
Bronchitis
|
---|---|
ICD |
ICD-11: CA20
|
Resistance Map |
Type(s) of Resistant Mechanism of This Disease
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Cefprozil
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Penicillin-binding protein 2B (PBP2B) | [1], [2], [3] | |||
Resistant Disease | Streptococcus pneumoniae infection [ICD-11: AA80.2] | |||
Molecule Alteration | Missense mutation | p.T445A |
||
Resistant Drug | Cefprozil | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
Genome sequence assay | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | MICs for and PBP affinities of the strains correlated with the changes found in the PBP active binding sites.The PBP2b T445-A substitution found in all PISP and PRSP and one PSSP has been found in all low-level Beta-lactam-resistant pneumococci examined. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.